Background. The influence of morphological status on the long-term outcome of patients undergoing liver resection for intrahepatic cholangiocarcinoma (ICC) is poorly defined. We sought to study the impact of morphological status on overall survival (OS) of patients undergoing curative-intent resection for ICC.
Methods. A total of 1083 patients who underwent liver resection for ICC between 1990 and 2015 were identified. Data on clinicopathological characteristics, operative details, and morphological status were recorded and analyzed. A propensity score-matched analysis was performed to reduce confounding biases. Results. Among 1083 patients, 941(86.9%) had a massforming (MF) or intraductal-growth (IG) type, while 142 (13.1%) had a periductal-infiltrating (PI) or MF with PI components (MF ? PI) ICC. Patients with an MF/IG ICC had a 5-year OS of 41.8% (95% confidence interval [CI] 37.7-45.9) compared with 25.5% (95% CI 17.3-34.4) for patients with a PI/MF ? PI (p \ 0.001). Morphological type was found to be an independent predictor of OS as patients with a PI/MF ? PI ICC had a higher hazard of death (hazard ratio [HR] 1.42, 95% CI 1.11-1.82; p = 0.006) compared with patients who had an MF/IG ICC. Compared with T1a-T1b-T2 MF/IG tumors, T1a-T1b-T2 PI/MF ? PI and T3-T4 PI/MF ? PI tumors were associated with an increased risk of death (HR 1.47 vs. 3.59). Conversely, patients with T3-T4 MF/IG tumors had a similar risk of death compared with T1a-T1b-T2 MF/IG patients (p = 0.95).
Conclusion. Among patients undergoing curative-intent resection of ICC, morphological status was a predictor of long-term outcome. Patients with PI or MF ? PI ICC had an approximately 45% increased risk of death long-term compared with patients who had an MF or IG ICC.
Intrahepatic cholangiocarcinoma (ICC) is a primary liver tumor that originates from the endothelial cells of segmental or proximal branches of the bile duct. 1 It accounts for 10-15% of all primary liver malignancies and its incidence and mortality are increasing worldwide. 2 Surgical resection remains the cornerstone of potentially curative therapy, however 5-year survival after curative-intent resection remains only 25-30%. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Several studies have identified clinicopathological factors associated with long-term outcomes. 2, 7, 9, [12] [13] [14] [15] [16] [17] [18] Specifically, preoperative cancer antigen (CA) 19-9 levels, tumor number and size, lymph node status, margin status, and vascular invasion have each been associated with an increased risk of death long-term. 2, 7, 9, [12] [13] [14] [15] [16] [17] 19 Another less-considered clinicopathological characteristic of ICC involves tumor morphology. The Liver Cancer Study Group of Japan has classified ICC into several categories based on gross appearance: mass-forming (MF) type, periductal-infiltrating (PI) type, and intraductal-growth (IG) type. The MF type is characterized by a defined mass within the liver parenchyma, while the PI subtype extends longitudinally along the bile duct, often with enhancement of the bile duct. In contrast, the IG type grows toward or within the lumen of the bile duct. 20 While these different ICC morphologies have been defined, few studies have investigated the impact of tumor morphology on long-term prognosis following resection of ICC. [21] [22] [23] Shimada et al. reported that MF ? PI ICC had a higher incidence of positive surgical margins, as well as a higher risk of local recurrence. 21 However, previous studies have been limited due to small patient cohorts derived from single institutions.
Given the lack of data, the objective of the current study was to define the impact of ICC morphologic status relative to long-term outcomes following liver resection for ICC using a large multi-institutional international cohort. In addition, we sought to define the relationship of tumor morphology and the American Joint Committee on Cancer (AJCC) 8th edition T categories.
INTRODUCTION PATIENTS AND METHODS

Study Population and Data Collection
Patients who underwent hepatic resection for histologically confirmed ICC at one of 14 major hepatobiliary centers between 1990 and 2015 were identified. Standard patient demographic and clinicopathological characteristics were collected, including age, sex, American Society of Anesthesiologists (ASA) class, presence of cirrhosis in the underlying liver, and serum level of carcinoembryonic antigen (CEA) and CA19-9. ICC-specific characteristics, including tumor location, tumor burden, invasion of adjacent organs, liver capsule involvement, margin status, tumor grade, major vascular/lymphovascular/perineural invasion, and nodal status were collected. For the purposes of analyses, patients were grouped as MF/ IG type versus PI/MF with PI components (MF ? PI) ICC. For all cases, the imaging and pathological data were reviewed to determine the macroscopic morphologic subtype. In addition, since early 2000, ICC morphological type has been included in the pathological report as a standard data field regarding tumor characteristics at the 14 participating centers. Treatment-related data such as type and extent of hepatic resection, lymphadenectomy, and receipt of neoadjuvant chemotherapy were also recorded. Tumor stage was categorized according to the 8th edition of the AJCC. 24 The presence of multifocal ICC, invasion of adjacent organs, liver capsule involvement, margin status, tumor grade, vascular/lymphovascular/perineural invasion, nodal status, morphological type, and AJCC stage were determined based on final pathological reports.
Statistical Analysis
Discrete variables were described as medians with interquartile range (IQR) and categorical variables were recorded as totals and frequencies. Univariable comparisons were assessed using the Chi square test or Fisher's exact test as appropriate. Univariable and multivariable analyses were performed using Cox proportional hazard regression models to assess possible associations among covariates. Variables significant on univariable analysis (p \ 0.05) were entered into the multivariable model and backward selection was used to eliminate nonsignificant variables at p \ 0.10. Furthermore, to account for any potential residual confounders in the effect of morphologic subtype classification on survival, propensity scores were estimated using a logistic regression model, with morphological type specified as MF/IG versus PI/MF ? PI. Age, ASA score, underlying liver disease, neoadjuvant chemotherapy, type of surgery, margin status, liver capsule involvement, invasion of adjacent organs, tumor size and number, tumor differentiation, major vascular invasion, lymphovascular invasion, perineural invasion, lymph node status, and AJCC 8th edition T-staging system were included as independent variables in the logistic regression model. For matching, a caliper width of 0.1 times the standard deviation of the propensity score was used. The degrees of covariate imbalance in unmatched and matched samples were measured using the standardized (mean and proportion) differences as proposed by Austin et al. 25 A p value \0.05 (two-tailed) was considered statistically significant. All analyses were performed using STATA version 12.0 (StataCorp LP, College Station, TX, USA) or R software for statistical computing, v. 3.0.2 34, with the additional packages, survival, Hmisc and Matching.
RESULTS
Baseline Characteristics of the Study Group Stratified by the Intrahepatic Cholangiocarcinoma Morphological Types
Among 1083 patients who underwent liver resection for ICC, 911 (84.1%) patients had a MF type ICC, 30 (2.8%) had an IG type, 54 (5.0%) had a PI type, and 88 (8.1%) patients had an MF ? PI type ICC. Accordingly, 941 (86.9%) patients were included in the MF/IG group, while 142 (13.1%) were included in the PI/MF ? PI group (Table 1) On final pathology, tumor size and number were comparable among patients with PI/MF ? PI versus MF/IG tumors, as was the incidence of poor/undifferentiated ICC tumors (Table 1 
Prognosis of Patients and Morphological Types
Given the baseline differences between the MF/IG and PI/MF ? PI groups, a propensity score-matching analysis was then performed to minimize potential confounding.
Patients were matched based on age, ASA score, underlying liver disease, neoadjuvant chemotherapy, type of surgery, margin status, invasion of adjacent organs, tumor size and number, tumor differentiation, vascular invasion, lymphovascular invasion, perineural invasion, lymph node status, and AJCC 8th edition T categories.
After the propensity score matching, 95 patients in the PI/MF ? PI group and 95 patients in the MF/IG group had comparable characteristics and were subsequently analyzed (electronic supplementary 
American Joint Committee on Cancer 8th edition T categories and Morphological Types
Patients were then stratified according to the AJCC 8th edition T categories, as well as morphologic subtypes (Tables 5, 6 ). A total of 749 (69.2%) patients were in the MF/IG group and in T1a-T1b-T2 stages compared with only 104 (9.6%) patients in the PI/MF ? PI group and T1a-T1b-T2 stages. Furthermore, 192 (17.7%) patients were in the MF/IG group and in T3-T4 stages, while 38 (3.5%) patients were in the PI/MF ? PI group and in T3-T4 stages. Of note, even among the T1a-T1b-T2 categories, patients with MF/IG morphology had a better 5-year OS of 41.6% (95% CI 36.9-46.3) versus 32.0% (95% CI 21.6-42.9) for patients with a PI/MF ? PI ICC (p \ 0.001). Similarly, among patients categorized as T3-T4, 5-year OS following resection of an MF/IG ICC tumor was 42.5% (95% CI 34.1-50.7) compared with only 5.6% (95% CI 0.5-20.6; p \ 0.001) for PI/MF ? PI ICC tumors (Fig. 2) . Moreover, compared with T1a-T1b-T2 MF/IG tumors, T1a-T1b-T2 PI/MF ? PI (HR 1.47, 95% CI 1.11-1.94) and T3-T4 PI/ MF ? PI (HR 3.59, 95% CI 2.46-5.23) lesions were associated with an increased risk of death. In contrast, patients with a T3-T4 MF/IG tumor had a comparable risk of death 
DISCUSSION
Similar to other solid malignancies, there has been significant interest in identifying clinicopathological factors associated with survival among patients undergoing curative-intent surgery for ICC. To this end, several groups have proposed various staging and prognostic schemes to stratify ICC patients with regard to prognosis. 2, 26 For example, Hyder et al. reported a nomogram that included six factors, including age, tumor size, number of lesions, nodal status, vascular invasion, and the presence of cirrhosis. 26 While the nomogram performed reasonably well, the overall accuracy was only moderate, with a C-statistic of 0.706. Such data suggest that other factors may be important in stratifying patient prognosis following resection of ICC. One such possible factor may be tumor morphology, which was first classified by the Liver Cancer Study of Japan. 20 To date, most studies on ICC have failed to consider, or even report, the morphologic subtype of ICC tumors included in the analytic cohort. 2,7,9,12-17 The current study is important because we were able to examine the impact of morphologic ICC subtype in a large, multicenter cohort of over 1000 patients undergoing surgery for ICC at one of 14 major hepatobiliary centers in the US, Europe, Australia, and Asia. Specifically, we noted that patients with an MF/IG ICC had a much more favorable prognosis compared with patients who had PI/MF ? PI tumors. In particular, PI/MF ? PI tumors were associated with many more aggressive features than MF/IG lesions. Interestingly, even after controlling for these competing risk factors, morphologic subtype remained associated with long-term survival. Moreover, when patients were stratified by the AJCC 8th edition staging, ICC tumor morphology was still associated with prognosis within T-category subgroups (Tables 5, 6 ).
Similar to previous reports, clinical variables associated with survival included lymph node status, tumor size and number, positive margin status, tumor grade, and lymphovascular and perineural invasion. 6, 27 More importantly, ICC morphologic type was also strongly associated with OS. Specifically, patients with an MF/IG ICC had a 5-year OS of 41.8% versus 25.5% for patients with a PI/MF ? PI tumor (p \ 0.001). Of note, after propensity score matching to control for potential confounding, MF/IG patients still were noted to have a better OS compared with patients who had PI/MF ?PI tumors (35.7% vs. 26.2%, respectively). These data were consistent with Shimada et al., who reported that patients with MF ICC tumors had a more favorable prognosis versus the MF ? PI subtype. 21 Furthermore, in a separate small study on 52 patients undergoing curative-intent surgery for ICC, Guglielmi et al. reported that patients with MF tumors (50 months) had a markedly longer median survival compared with either the MF/PI subtype (19 months) or the pure PI subtype (15 months). 28 In addition, in the current study, the MF ? PI ICC subtype was associated with more aggressive tumor characteristics, which was consistent with the study by Shimada et al., which reported MF ? PI ICC Similarly, in a recent paper from our group comparing the AJCC 7th versus 8th edition staging systems for ICC, 8th edition T3 patients paradoxically had a better 5-year OS than either T1 or T2 patients. 29 These data, in conjunction with data from the current study, suggest that factors other than those currently included in the AJCC staging manual are needed to improve prognostication of survival among patients with ICC. The current paper had several limitations that should be considered. The retrospective nature of the study may have resulted in selection bias; however, such confounding was unlikely to impact the evaluation of the prognostic effect of the morphological status. The multi-institutional nature of the study likely also caused some heterogeneity in ICC treatment approach. Finally, the pathological evaluation of ICC was conducted separately in each center, resulting in some heterogeneity in the interpretation of the pathological ICC characteristics. However, including multiple tertiary referral hepato-pancreatico-biliary (HPB) centers allowed for a large sample size and a more 'real-world' cohort.
CONCLUSION
Among patients undergoing curative-intent resection of ICC, morphologic subtype was associated with long-term outcome. In particular, patients with PI or MF ? PI ICC had an approximately 45% increased risk of death compared with patients who had an MF or IG ICC. Interestingly, T3-T4 MF/IG patients had a similar risk of death as T1a-T1b-T2 MF/IG patients. Collectively, these data suggest that further refinements of staging, such as including tumor morphology, may be needed to better define the prognosis of patients with ICC. 
